655 related articles for article (PubMed ID: 26711836)
1. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
2. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of 105 cases with uterine sarcoma.
Yoney A; Eren B; Eskici S; Salman A; Unsal M
Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
[TBL] [Abstract][Full Text] [Related]
9. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma.
Cabrera S; Bebia V; Acosta U; Franco-Camps S; Mañalich L; García-Jiménez A; Gil-Moreno A
Clin Transl Oncol; 2021 Jun; 23(6):1210-1219. PubMed ID: 33210235
[TBL] [Abstract][Full Text] [Related]
12. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
13. Uterine sarcoma: a clinicopathological study of 93 cases.
González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J
Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834
[TBL] [Abstract][Full Text] [Related]
14. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
[TBL] [Abstract][Full Text] [Related]
15. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands.
Benito V; Lubrano A; Arencibia O; Andújar M; Alvarez E; Medina N; Falcón JM; Falcón O
Int J Gynaecol Obstet; 2009 Oct; 107(1):44-9. PubMed ID: 19555952
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors.
Rothmund R; Hartkopf A; Joachim C; Walter CB; Wallwiener M; Kraemer B; Brucker SY; Staebler A; Taran FA
Arch Gynecol Obstet; 2014 Dec; 290(6):1195-200. PubMed ID: 24981048
[TBL] [Abstract][Full Text] [Related]
20. Uterine sarcoma: twenty-seven years of experience.
Livi L; Paiar F; Shah N; Blake P; Villanucci A; Amunni G; Barca R; Judson I; Lodge N; Meldolesi E; Simontacchi G; Piperno G; Galardi A; Scoccianti S; Biti GP; Harmer C
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1366-73. PubMed ID: 14630275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
